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Abstract
Background:  The in vitro culture of insulinomas provides an attractive tool to study cell
proliferation and insulin synthesis and secretion. However, only a few human beta cell lines have
been described, with long-term passage resulting in loss of insulin secretion. Therefore, we set out
to establish and characterize human insulin-releasing cell lines.
Results: We generated ex-vivo primary cultures from two independent human insulinomas and
from a human nesidioblastosis, all of which were cultured up to passage number 20. All cell lines
secreted human insulin and C-peptide. These cell lines expressed neuroendocrine and islets
markers, confirming the expression profile found in the biopsies. Although all beta cell lineages
survived an anchorage independent culture, none of them were able to invade an extracellular
matrix substrate.
Conclusion: We have established three human insulin-releasing cell lines which maintain antigenic
characteristics and insulin secretion profiles of the original tumors. These cell lines represent
valuable tools for the study of molecular events underlying beta cell function and dysfunction.
Background
A major obstacle in beta cell research has been the lack of
a human pancreatic beta cell line that is functionally
equivalent to primary normal or neoplastic beta cells
because of difficulties in obtaining and culturing them for
long periods of time [1,2]. Therefore, animal insulinoma
cell lines are widely used to study both physiological and
pathophysiological mechanisms involved in glucose
metabolism and to establish in vitro models for the beta
cell damage occurring in type 1 diabetes [3-8]. Neverthe-
less, recent studies comparing sequences that lie upstream
of, or flank the transcription start site of the insulin gene
among different species, led to the conclusion that the
rodent promoters are markedly different from the human
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one, urging caution in extrapolating data from rodent pro-
moter studies to the etiology and therapy of diabetes [9].
Insulinomas are the most common pancreatic islet cell
tumors, arising from the beta cells within the islets of
Langerhans. Most of them are sporadic [10] and small,
displaying a benign behaviour, but still cause substantial
morbidity since they produce excessive amounts of hor-
mones. In fact, their key hallmark is uncontrolled insulin
secretion, despite hypoglycemia. Compared with normal
beta cells, insulinomas also tend to secrete more proinsu-
lin, leading to an increased ratio of proinsulin to insulin
[10-12].
Although the clinical association between hypoglycemia
and pancreatic beta cell tumors was already described in
1927 [13], the molecular mechanisms involved in this
disease remain unknown. Histochemical studies in
human insulinomas showed that tumors have reduced
insulin protein content compared with normal beta cells;
hence it is possible that decreased storage capacity and
uncontrolled hormone release are responsible for the
hyperinsulinemia [11].
Persistent hyperinsulinemic hypoglycemia of infancy
(PHHI), or nesidioblastosis, is a rare disorder character-
ized by unregulated insulin secretion and profound
hypoglycemia [14]. PHHI could also be characterized by
the histological appearance of endocrine cells lying in the
duct epithelium, with an apparent failure to aggregate
into discrete islets of Langerhans [15]. However, there is
some controversy on the etiology of the disease because
severe hypoglycemia can also occur in the presence of
apparently normal islets [16].
To the best of our knowledge, the number of human cells
growing in vitro which persistently release insulin is lim-
ited [17-19].
In view of the great demand for easily accessible beta cell
lines for physiological and medical relevant studies [9],
we set out to generate and characterize human insulin-
releasing long term cell cultures derived from biopsies of
insulinomas and nesidioblastosis.
Here, we describe three new insulin-releasing low passage
cell lines, derived from two independent insulinomas
(APM and CPR cell lines) and one nesidioblastosis (VGA
cell line)that maintain the antigenic characteristics and
insulin secretion profile of the original tissues at least for
up to 20 cell passages.
Although the behaviour of these cell lines does not per-
fectly mimic the primary beta cell physiology, they are
extremely valuable tools for developing bioengineered
beta cells offering unique opportunities to investigate
complex aspects of tumor biology, insulin secretion and
beta cell function.
Results
Primary cultures and establishment of cell lines
Three ex-vivo primary cultures (APM, VGA and CPR) were
obtained from independent donors after surgical resec-
tion of the tissue and cell processing. Cells were success-
fully grown as monolayers up to passage number 20 (25
weeks approximately), showing fibroblastic-like mor-
phology. All cell cultures were characterized by an overall
2-dimensional growth pattern. Nevertheless, all of them
also presented the capacity to form cell clusters (Fig. 1A).
In order to confirm their human origin, diploid condition
and chromosomal structure, we karyotyped all three cell
lines. Cells at passages 12, 7 and 11 for, respectively, APM,
CPR and VGA lines were karyotyped following standard
techniques, as described in Material and Methods section.
This procedure confirmed the human origin of all three
cell cultures and also showed an unaltered number of
chromosomes, when compared to normal human cells.
Interestingly, CPR cells presented a chromosomal abnor-
mality in mosaicism on chromosome 22 (karyotype of
CPR cells: 46, XY, der (22)/46, XY) (Fig. 1B).
Functional analysis and cell lines characterization
In order to approach the cell cultures characterization, we
studied, by confocal immunoflourescence (IF) micros-
copy, several pancreatic islet markers, such as insulin, glu-
cagon, C-peptide, Glut-2 and PDX-1, as well as ductal
(cytokeratin 19), mesenchymal (alpha-actin, desmin and
vimentin) and one of the endocrine pancreatic tumor
(chromogranin) cell markers. As shown in Fig. 1C, while
APM cells were positive for chromogranin, PDX-1 and
insulin, and VGA cells showed a positive staining for
chromogranin, PDX-1, Glut-2 and glucagon; only CPR
cells presented a positive staining for chromogranin plus
all the beta cell markers analysed (PDX-1, insulin, C-pep-
tide and Glut-2). It is important to note that, almost all of
the cells of each cell culture analyzed, presented the same
staining pattern described above. Nevertheless, a cell pro-
portion of less than 1% was desmin, alpha-actin, vimen-
tin or CK19-positive (see Additional file 1).
Next, we also investigated the mRNA expression levels of
some neuroendocrine and exocrine markers by means of
RT-qPCR. In general, all of the genes studied presented
positive expression. In order to follow the evolution of the
cell cultures, the data shown in figure 2 represent the
means of, at least, three experiments performed with
mRNA samples obtained from different cell passages.
Interestingly, all cell lines presented less than 1% of
chromogranin and insulin expression when compared
with human islet cultures, set as 100%. As previously
reported [17,20], our cell lines also showed lower levels ofBMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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Human beta cell cultures growing in vitro Figure 1
Human beta cell cultures growing in vitro. Morphological and immunofluorescence studies performed on cells from pas-
sages 5 to 15. (A) Cells (1 × 104 cells/well) obtained from human insulin secreting cell cultures, were incubated for 4 days in 
CMRL medium containing 0.5% FCS. 2-dimensional, expansive growth pattern (top panel) and a cluster-like, 3-dimensional type 
of growth (bottom panel). Representative fields (x100) were photographed under a phase-contrast Nikon microscope. (B) 
Representative G-banded karyotype of VGA (46, XX) (upper left panel); APM (46, XY) (upper right panel) and CPR cells (46, 
XY) (bottom left panel) and (46, XY, der(22)) (bottom right panel, black arrow indicates chromosome 22 alteration). (C) 
Immunoflourescence confocal microscopy. After fixation and permeabilization, the cells were labeled with antibodies against 
chromogranin A(green) and alpha-actin (red) (top left panels), insulin (green) and desmin (red) (middle left panels), glucagon 
(green) and desmin (red) (bottom lef panels), Glut2 (green) and vimentin (red) (top right panels), C-peptide (green) and vimen-
tin (red) (middle right panels) or PDX1 (green) and cytokeratin 19 (red) (bottom right panels). In all cases nuclei were stained 
with DAPI (blue). A representative field is shown. Bar: 50 μm.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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the beta cell potassium – ATP channels subunit SUR1
(APM: 0.18 ± 0.03%; VGA: 0.16 ± 0.03%; CPR: 12 ± 1%)
and reduced levels of the prohormone convertase 1 and 2
(PCSK1 and 2) (for PCSK1: APM: 2.1 ± 0.4%; VGA: 1.36
± 0.1%; CPR: 58 ± 3%. For PCSK2: APM: 0.3 ± 0.1%; VGA:
0.2 ± 0.1%; CPR: 1.0 ± 0 1%). In agreement with the
immunohistochemistry data from the biopsies and the
immunofluorescence performed in the cell cultures, glu-
cagon mRNA levels were barely detected only in CPR and
VGA cells (Fig. 2). Furthermore, in order to control for the
proportion of exocrine pancreatic cells, the cell lines amy-
lase levels were also monitored. All cell lines presented a
very low abundance of exocrine cells as shown by the
almost undetectable amylase mRNA levels detected
(Fig. 2).
Cells lines were periodically monitored, from the begin-
ning of the primary cultures and every three cell passages,
for intracellular hormone content and release and, also,
for glucose-induced insulin secretion to select for func-
tional beta cell populations. As shown in Table 1, all three
cell cultures presented greatly increased accumulated
insulin and proinsulin release (aproximately 100 times
the values obtained from the primary cultures of human
pancreatic islets). Moreover, in accordance with the
described behaviour of insulinomas, decreased C-peptide
release and barely detectable insulin content were also
observed in these cultures. Furthermore, no insulin secre-
tion response was observed upon exposure of the cells to
high concentrations of glucose (20 mM), showing no
capacity to respond in a physiological manner to
increased glucose concentration (Table 1).
Cell growth properties
In order to establish the growth parameters of the cell cul-
tures, we compared their growth in the presence of 10%
FCS and determined the doubling times for each one of
them. As shown in figure 3, APM, CPR and VGA cells dis-
played similar growth curves, presenting a doubling time
of approximately 40 h (APM: 38.5 ± 0.3 h; VGA: 40.5 ± 0.3
h; CPR: 42 ± 1 h).
We also set out to study the cell behaviour of these cul-
tures upon treatment with a panel of growth factors and
hormones, which have been described as proliferation
inducers in cancer. We determined that all three human
cell lines cultures presented similar proliferation patterns.
While none of them responded to epidermal growth fac-
tor (EGF) at any tested concentration; either Insulin-like
growth factor 1 (IGF-1) or recombinant human prolactin
(rhPRL) induced a significant growth increase (p < 0.05)
on APM, CPR and VGA cells, the highest stimulation rate
being exerted at 20 ng/mL and 300 μg/mL for IGF-1 and
rhPRL, respectively (Fig. 3B–D) Moreover, simultaneous
stimulation with rhPRL and IGF-1, at suboptimal concen-
trations, had no additive effect on cell proliferation (Fig.
3E).
Next, we evaluated the clonogenic ability of the cell lines,
defined as the capacity of isolated cells to form colonies.
We demonstrated that VGA, CPR and APM cells were una-
ble to form colonies when seeded at low density (data not
shown).
On the other hand, the anchorage-independence was also
tested by seeding the cells onto an agar overlay. As shown
in figure 4, when adhesion to a substrate was prevented,
all cell lines formed spheroids, but only APM cells were
able to proliferate under this condition (evaluated at 4
days after seeding).
VGA, CPR and APM cells growing in 96-well plates were
incubated with increasing doses of Doxorubicin (Doxo)
(0.75, 1.5, 3, 6 and 12 μM), and cell viability was evalu-
ated 48 h after treatment by means of MTS, as described in
Material and Methods. We observed that only CPR cells
were sensitive to Doxo, exhibiting an IC50 of 5.1 μM (Fig.
5A).
The suceptibility of the human beta cell lines to serum
starvation was also studied. Subconfluent monolayers
were incubated for 96 h in the absence of FCS and the via-
bility was then measured using MTS assay. As shown in
figure 5B, APM cells were 1.5 fold more susceptible to
serum starving than VGA cells.
Adhesiveness ability and expression of adhesion molecules
We first examined the adhesiveness ability of CPR and
APM cells to different substrates. As shown in figure 6A
adhesion to plastic, to control substrate, to fibronectin
(FN) and to Col IV was similar between all of the human
beta cell lines. More over both insulinoma cell cultures
presented more adhesiveness to Laminin (LN) (Fig. 6A)
Integrins are a family of cellular transmembrane receptors
that recognize different extracellular matrix components,
such as FN. By Western blot (WB) and IF analysis, we
show that all insulinoma cell lines express similar levels of
β1-Integrin (Fig. 6B).
Since the expression of E-Cadherin, a 120 kDa transmem-
brane glycoprotein, is associated with cell-cell adhesion,
we next examined its expression at the protein level. We
observed that only APM cells were positive for E-Cad-
herin, as detected by WB and IF (Fig 6B). Classical cadher-
ins are defined by their ability to form complexes with
catenins. We found that all insulinoma cell lines
expressed  β-Catenin, without significant differences
among them (Fig. 6B).BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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mRNA expression levels of endocrine and exocrine markers Figure 2
mRNA expression levels of endocrine and exocrine markers. Insulin, chromogranin, SUR1, PCSK1, PCSK2, glucagon, 
and amylase were measured by Real-time RT-PCR reaction using SYBR® Green Dye reagent (Applied Biosystems, Foster City, 
CA, USA). All reactions were performed in triplicates (n = 4 independent experiments). The relative expression of a target 
gene was determined in comparison to a reference gene (HPRT). In addition H-MBS mRNA-expression level was used as a 
positive control for similar expression levels between cell lines and human islets. Results are presented as relative increase 
where the value obtained from primary cultures of human islets was set to 100. a p < 0.001. APM, VGA or CPR cells vs. human 
islets. For SUR1 and PCSK1mRNA levels: a p < 0.001. APM, VGA or CPR cells vs. human islets, and also CPR vs. APM or VGA 
cells. ANOVA/Bonferroni's tests.
Table 1: Accumulated insulin, C-peptide and pro-insulin release and insulin content.
VGA APM CPR hBeta-cells
Insulin release (ng/ngDNA) 5 × 10-2 ± 1 × 10-2 2.5 × 10-2 ± 3 × 10-3 9 × 10-3 ± 1 × 10-3 9 × 10-5 ± 1 × 10-5
Insulin content (ng/ng DNA) <3 × 10-7 <3 × 10-7 <3 × 10-7 3 × 10-4 ± 1 × 10-4
Pro-Insulin release (pmol/ng DNA) 8 × 10-4 ± 2 × 10-4 3 × 10-4 ± 3 × 10-5 3 × 10-4 ± 1 × 10-5 N.D.
C-peptide release (ng/ng DNA) 5 × 10-2 ± 1 × 10-2 5 × 10-2 ± 1 × 10-2 5 × 10-2 ± 1 × 10-2 5 × 10-2 ± 1 × 10-2
Glucose-induced insulin secretion (Stimulation Index)a 11 1> 3
a Stimulation Index = Insulin secretion (20 mM glucose): Insulin release (2.8 mM glucose)
N.D.: not detectedBMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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Spreading, migration and invasion abilities
The percentage of spreading cells was determined 45 min
after plating by scoring cell morphology under a phase-
contrast microscope. We determined that while 60% of
VGA cells showed a flattened round base and lamella or
filopodia extensions (spreading group), APM and CPR
cells presented only 30% of spreaded cells (Fig. 7A).
"Wound-healing" assay was used to analyze the in vitro
migration ability of the human beta cell lines. Four hun-
dred μm wide wounds were made in confluent monolay-
ers of the different cell cultures, including primary
cultures of human normal islets, and migration into the
cell-free area was observed and measured. While at 18 h
after the initial wound was made VGA cells had covered
about 30% of the cell-free area, CPR and APM cells
showed a significantly lower migratory ability, covering
less than 15% of the original wound in the same time
period. Interestingly, we determined that primary cultures
from normal human islets completely closed the wound
during this same time period (Fig. 7B).
We also analyzed the invasive capacity using "Transwell"
chambers, with filters of 8 μm pores covered with the recon-
stituted basal membrane Matrigel. Twenty two hours after
seeding, the number of insulinoma cells that invaded the
Cell growth features Figure 3
Cell growth features. (A) Cells were maintained in adherent dishes for up to 168 h in CMRL medium containing 5.6 mM glu-
cose and 5% FCS. After 24 h, 48 h, 72 h, 120 h and 168 h, cells were harvested and counted. Data are presented as the mean 
of three independent experiments (n = 3 for each experiment) ± s.d. Doubling times were calculated from these data using 
PRISM4 ® software. (B) Cells were seeded, in triplicate, in 24 multiwell plates. After 24 h, cells were serum starved for 24 h and 
then subjected to a 48 h treatment with either: EGF; (C) IGF-1, a vs b, c, d, e; b vs c: p < 0.001; (D) rhPRL, a vs c, d; b vs c, d: 
p < 0.001;(E) a combination of IGF-1 and rhPRL, a vs b, c; b vs d; c vs d: p < 0.001; or their corresponding vehicles. Cells were 
then harvested, fixed and counted. Data are presented as the mean of three independent experiments ± SEM.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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Matrigel and the filters was evaluated by means of an
inverted microscope. However, no invasion was found either
in AMP, VGA or CPR cells (data not shown).
Proteases secretion profile
Proteases are expressed in normal processes but also, in a
non-regulated manner, during pathological events as tis-
sue invasion and metastasis. Among the principal pro-
teases associated with the invasive capacity of tumor cells
are the metalloproteinases (MMPs) and the serine pro-
tease uPA. Therefore, we evaluated uPA, MMP-9 and
MMP-2 activity secreted to the conditioned medium of
the human cell lines. All cell lines were able to secret
MMP-9, with no differences among the cell types (Fig. 8).
However, none of the analyzed cells appeared to be secret-
ing MMP-2 (data not shown).
Constitutive uPA activity was very low in all cell types,
being detectable only in VGA cells (3.08 × 10-5 ± 6.9 × 10-
6 UI/μg of protein, data not shown).
Discussion
Most insulinomas are derived from monoclonal prolifer-
ation of pancreatic islets beta cells; therefore, they consti-
tute good models for studying both tumor and beta cell
biology.
Here, we report the morphological and cytogenetic features,
as well as the biological behaviour, of three long term cul-
tures of insulin producing human cells derived from two iso-
lated insulinomas and one nesidioblastosis case. To the best
of our knowledge, the number of in vitro grown, persistently
insulin-secreting human cells is very limited. Recently, the
Anchorage-independent growth Figure 4
Anchorage-independent growth. APM, VGA and CPR cells were seeded in suspension in complete medium containing 
10% FCS. At 4 days, cell nuclei were stained with propidium iodide, photographed and the spheroids formed were evaluated. 
Values were obtained from duplicate measures, in three independent experiments. Representative pictures are shown. The dif-
ference among clones was statistically significant. a p < 0.001 vs CPR cells, b p < 0.01 vs VGA cells, c p < 0.05 vs VGA and CPR 
cells. ANOVA/Bonferroni's tests.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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human glucose-responsive insulin secreting NES2Y cell line,
derived from a patient with persistent hyperinsulinemic
hypoglycemia of infancy, was established. This cell line was
characterized as presenting a population doubling time of
approximately 24 h, an insulin promoter unresponsive to
glucose, a lack of ATP-sensitive potassium channel and a
defect in the PDX1 insulin gene-regulatory transcription fac-
tor [17,20,21]. Moreover, two years ago, Gartner and collab-
orators described a few characteristics of eight long-term
insulin-secreting cell cultures maintained in vitro [19]. So
far, the only human insulinoma-derived cell line (CM) lacks
persistent and glucose-induced insulin secretion and
presents several chromosomal abnormalities, specifically
including the chromosome 11 tetraploidy, with three out of
four chromosomes 11 being aberrant and showing a chro-
mosomal material translocation at a specific locus of the
human insulin gene [2,22].
The cell lines described here displayed the same antigenic
and insulin secreting profiles as the original tumors. It is
important to note the fact that the barely detectable intra-
cellular insulin levels is in accordance with the description
of insulinomas as having poor or almost non-existent
capacity for insulin storage, thus presenting no positive
staining for insulin [20,23]. Unlike the CM cells, our cell
cultures presented large amounts of human insulin secre-
tion which was maintained throughout the different pas-
sages, in addition to an unaltered number of
chromosomes and only an insertion in mosaicism on
chromosome 22 in the CPR cells.
In agreement with the very well characterized excessive
and/or uncontrolled insulin release, displayed by insuli-
nomas and nesidioblastosis [24,25], none of our cell cul-
tures presented glucose-induced insulin secretion. It has
been suggested that the histological resemblance of nesio-
dioblastotic pancreata to those of immature fetuses may
have arisen as the result of inappropriate control during
the earliest phases of endocrine pancreatic development
[26]. Further results supported this conclusion, adding
that in nesidioblastosis, this similarity is not only ana-
tomic, but also functional, because of their defective rec-
ognition of nutrient secretagogues, and lack of glucose
dependence of their cAMP mediated insulin release [27].
Furthermore, the lack of glucose-regulated insulin secre-
tion, observed in our human insulin-producing cell lines,
might be attributed to the loss of the sulphonylurea recep-
tor gene (SUR1) which would lead to the absence of func-
tional ATP-sensitive potassium channels.
The elevated levels of proinsulin detected in our cultures,
could be related on one hand, to diminished mRNA levels
of prohormone convertase 1 and 2 displayed in these cell
lines. These enzymes are responsible for cleavage of proin-
sulin and thus are involved in the presence of this insulin
precursor in secretory granules. On the other hand, it has
already been reported that unlike normal pancreatic beta
cells, in which proinsulin to insulin conversion occurs in
acidic immature secretory granules of the trans-Golgi
apparatus, in insulinomas, this conversion already takes
place in the Golgi apparatus, but remains incomplete,
resulting in the formation of secretory granules containing
both proinsulin and insulin. This indicates that in insuli-
nomas, sorting into secretory granules may not be a pre-
requisite for hormone conversion [20].
It is important to note that, probably due to their benign
nature, the cell lines generated in our work presented sev-
Susceptibility to cell death induction Figure 5
Susceptibility to cell death induction. APM, VGA and CPR cells were treated with increased doses of Doxorubicin (0.75–
12 μM) (A) or were incubated in serum free medium for 96 h (B). Cell viability was determined using the MTS assay. The 
results are representative of three independent experiments. Each value represents the mean ± SD of triplicate determina-
tions. a p < 0.001. ANOVA/Bonferroni's tests.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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eral growth features, including dependence of trophic fac-
tors, reduced clonogenic ability and capacity to form cell
clusters, which are similar to those found in human nor-
mal islet primary cultures. The human insulin-releasing
cell lines described here presented a relatively low prolif-
eration rate, which appears to be in agreement with the
already published data and also with the rate found in
human islet primary cultures [20,28]. Moreover, this low
proliferation rate could explain the resistance to doxoru-
bicin treatment observed in our cultures, since this kind of
compounds has been associated with low success rates in
well-differentiated tumors [29] and are only used in
malignant insulinoma treatment [30].
Among the panel of growth factors tested, only IGF-1 and
rhPRL were able to induce cell proliferation of our cell
lines. Several studies have pointed IGF-1 as a growth pro-
moter for beta cells [31-33]. Furthermore, the mitogenic
activity of the lactogen family of hormones, which include
prolactin, have also been described for normal and neo-
plasic human beta cells [19,28].
Metastasis is the process by which tumor cells establish
new tumor foci at different and distant organs. This is a
very complex multistep process, in which each step is cru-
cial and strictly regulated. Acquisition of invasive ability
involves changes in adhesion, migration and extracellular
Adhesiveness ability and pattern of expression of adhesion molecules Figure 6
Adhesiveness ability and pattern of expression of adhesion molecules. (A) APM and CPR cells were allowed to attach 
to FN, LN, Col IV or BSA (control) coated wells. The rate of cell adhesion at 2 h was expressed as the percentage of the total 
number of cells seeded. The results are representative of three independent experiments. Each value represents the mean ± 
SD of triplicates. a p < 0.001 APM FN vs APM plastic, and CPR FN vs CPR LN, CPR plastic and CPR BSA. b p < 0.005 APM FN 
vs APM BSA, and APM LN vs APM plastic. c p < 0.05 APM FN vs APM Col IV, APM LN vs APM BSA, APM LN vs CPR LN, and 
CPR FN vs CPR Col IV. ANOVA/Bonferroni's tests. (B) Expression of β1-Integrin, E-Cadherin and β-Catenin was analyzed by 
Western blot and Immunofluorescence as described in Materials and Methods. Representative images are shown.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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proteolysis, culminating in shedding of tumor cells into
the circulation [34]. Few studies focusing on cell migra-
tion and invasion properties of endocrine pancreatic
tumor cells (EPTs) are available. We evaluated every step
of this process in our cell models.
Firstly, the migration capacity of our cell cultures was
compared with that displayed by human islet primary cul-
tures. The results showed that even when all the insulin-
releasing cultures presented very low migration, the motil-
ity of the neoplastic cells was very low, and surprisingly,
this ability increased in hyperplastic (nesidioblastosis)-
derived VGA cells. This result is in agreement with the
higher spreading capacity detected in these cells. The high-
est migration values were obtained in primary cultures of
normal human islets. It remains to be elucidated which
are the causes of this unexpected cell behaviour.
We next examined the adhesiveness ability of CPR and
APM cells, determining that adhesion to plastic, to control
substrate, to FN and to Col IV was similar between all of
the human beta cell lines. Both insulinoma cell cultures
were more adhesive to LN. The differences found in the
adhesion pattern could be explained by variations in the
expression profiles of adhesion molecules. FN is an extra-
cellular protein which binds cells via specific integrins. In
agreement with the similar adhesiveness to FN, we found
no differences in β1-Integrin expression between the cell
lines. Moreover, the only report we found, focused on
down regulation of E-cadherin, a homotypic cell-to-cell
interaction molecule ubiquitously expressed in epithelial
cells, reported on the RIP-Tag model but, so far this has
not been confirmed by studies on primary EPTs [35]. In
our work, we found a lack of E-Cadherin expression in
two out of three human beta-cell lines studied. We
showed, for the first time, that the APM human insuli-
noma derived cells, the only one presenting positive stain-
ing for E-cadherin, also displayed the lowest MMP-9
activity. These facts could, at least in part, explain the poor
migration ability of this cell line, correlating with the
benign behavior of the original tumor. Cadherins are
linked to the actin cytoskeleton through catenins and, in
particular,  β-Catenin binds directly to the intracellular
domain of E-Cadherin. Surprisingly, and in spite of the
differences found in the E-cadherin expression, all insuli-
noma cells presented similar levels of β-Catenin. There-
fore, it is possible that the β-Catenin found in the VGA
and CPR cells is involved in other cellular functions, inde-
pendently of adhesion.
Cell spreading and migratory ability Figure 7
Cell spreading and migratory ability. (A) Cells from the different human insulin-producing cell lines were seeded and 
allowed to adhere for 60 min. After removal of non adherent cells, the percentage of spread-out cells was determined at 45 
min. Data were collected by random observation and at least in triplicate. a p < 0.001. ANOVA/Bonferroni's test. (B) Conflu-
ent monolayers of the human cell lines and of normal islets were "wounded". The cells were allowed to migrate into the cell-
free area for 18 h and then photographed. Cell migration was evaluated by densitometry, calculating the area occupied by the 
migratory cells. Migration is expressed as the percentage (mean ± SD) of wound covered area. a p < 0.001 normal islets vs cell 
lines. b p < 0.001 VGA vs APM and CPR cells. ANOVA/Bonferroni's test.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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Overall, the results related to cell invasion and migration
of these cultures are in agreement with the ones found in
hyperplasic cells or benign tumors from which these cul-
tures were derived, indicating that the cells maintained
the original characteristics throughout the cell passages.
These human insulin-releasing cell lines have been char-
acterized in detail, and express several key features of nor-
mal pancreatic beta cells, such as expression of a number
of islet genes (e.g.: insulin, PDX-1, Glut2, Prohormone
convertases, glucagon) and formation of cell clusters.
Conclusion
The cell lines described in this work represent, even when
their behaviour do not perfectly mimic the primary beta
cell physiology, valuable tools for the study of the molec-
ular events underlying beta cell function and dysfunction.
The merits which become evident from the characteriza-
tion and use of APM, CPR or VGA cells in diverse func-
tional studies reported here, should be balanced against
the short lifespan of primary beta cells which also
undergo a rapid decline in their function and granulation
with time in culture.
It is important to say that, we are currently performing
comparative proteomic studies, in order to further charac-
terize the differences between normal human islets cul-
tures and these cell lines.
Collectively, these observations prompt research towards
successful establishment of bioengineered human beta
cells, providing a large and much needed source of cul-
tured human beta cell tissue for experimentation. More
over, the cell lines described here could also be useful to
improve the knowledge on the molecular biology of
insulinomas in order to select and/or validate new thera-
peutic targets and diagnostic biomarkers.
Methods
Patients' data
Three ex-vivo primary cultures (APM, CPR and VGA cells)
were obtained from independent donors after surgical
resection and tissue processing. The tissue samples were
processed after informed consent was obtained from
patients enrolled in a protocol of the bile ducts and pan-
creas service, approved by the institutional board of the
Hospital das Clínicas, FMUSP. APM and CPR cultures
were established from biopsies of isolated insulinomas of
men aged 27 and 22 years old, respectively. The diagnosis
of insulinoma was confirmed by high insulin, C-peptide,
and proinsulin plasma concentrations with low glucose
levels during a 19 h supervised fast. The tumors were
localized by calcium-stimulated selective arteriography.
Both patients underwent a curative surgical tumor resec-
tion that resulted in full resolution of their symptoms. The
tumor diagnosis was further confirmed by immunohisto-
logical analysis. All tumors stained for insulin, chrom-
ogranin and synaptophysin.
VGA cells were obtained from a woman aged 23 years old
presenting no tumor and high insulin, C-peptide, and
proinsulin plasma concentration with low glucose levels
during a 19 h supervised fast. A partial pancreatectomy
was performed in this patient and nesiodioblastosis was
diagnosed by means of histopathological analysis. The
biopsy presented positive staining for insulin, glucagon,
somatostatin, chromogranin and synaptophysin.
Primary cultures derived from insulinomas and 
nesidioblastosis
Primary cultures were obtained by mechanical fragmenta-
tion and enzymatic digestion of solid fragments with Lib-
erase (Roche biodiagnostics, Indianapolis, IN). Several
fractions containing different cell populations were sepa-
rated by serial sedimentation and centrifugation steps.
The cells were plated in culture flasks with CMRL 1066
(Mediatech-Cellgro, Miami, FL) supplemented with ITS
(insulin 10 mg/L, transferin 5.5 mg/L, sodium selenite
0.0067 mg/L, ethanolamine 2 mg/L, Invitrogene, Cars-
bald, CA), penicillin 100 units/mL, 10% fetal calf serum
(FCS, Cultilab, Campinas, SP, Brazil) and glucose (final
concentration 11 mM) and allowed to attach for 24 to 48
h. In all cases, culture media were changed every 2–3 days.
Profile of secreted proteases Figure 8
Profile of secreted proteases. Conditioned medium were 
individually harvested from each human insulin-producing cell 
line. In quantitative zymography of MMP9, the gelatinolytic 
bands (inset) were visualized by negative staining and meas-
ured with an image analyzer. Each value represents the mean 
± SD of triplicate determinations.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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At confluence or when every cell clusters appeared over-
crowded, the cells were detached with 0.025% trypsin,
washed, and resuspended in fresh medium. All cell cul-
ture experiments were performed at 37°C in a humidified
atmosphere containing 5% CO2.
Human islet isolation and cell culture: Human pancreas
from adult brain-dead donors (mean age 50 ± 3 years, n =
7) were harvested in conformity with Brazilian regula-
tions and the local Institutional Ethical Committee. Pan-
creatic islets were isolated by the automated method of
Dr. Ricordi and collaborators [36] with previously
described modifications [28,37].
The islets were first maintained in CMRL 1066 medium
supplemented with 100 units/ml penicillin and 5% fetal
calf serum FCS at 37°C in a humidified atmosphere a
humidified atmosphere containing 5% CO2.
Immunofluorescence (IF)
Cultured cells were trypsinized and plated onto glass cov-
erslips in a 24-well plate at a density of 1 × 104 cells/well
and grown for 3–7 days. Cells were then washed, fixed,
permeabilized and incubated with the corresponding
antibodies as previously described [28]. The following pri-
mary antibodies were used: rabbit polyclonal anti-hInsu-
lin (ICN, Aurora, OH), rabbit polyclonal anti-homeobox
domain transcription factor Pdx1 [38] (kindly donated by
Dr. C.V. Wright, Department of Cell Biology, School of
Medicine, Vanderbilt University), rabbit polyclonal anti-
hGlucagon (Zymed Laboratories Inc., San Francisco, CA),
mouse monoclonal anti-hCytokeratin 19 (ICN, Cosa
Mesa, CA), mouse monoclonal anti-Vimentin (Sigma, St.
Louis, Mo), mouse monoclonal anti-Desmin (Sigma, St.
Louis, Mo), mouse monoclonal anti-alpha Actin (Sigma,
St. Louis, Mo), rabbit polyclonal anti-hGlut2 (Chemicon,
Temcula, CA), rabbit polyclonal anti-hChromogranin A
(DakoCytomatation, Danemark), rabbit polyclonal anti-
hC-peptide (Linco Research, St. Charles, MO), mouse
monoclonal anti-α1-Integrin (clone W1B10, Sigma),
mouse monoclonal anti-E-Cadherin (clone 32, Transduc-
tion Laboratories) and mouse monoclonal anti-β-Catenin
(clone 14, Transduction Laboratories). The primary anti-
bodies were detected with fluorescent labeled secondary
antibodies (Vector Laboratories, Burlingame, CA) and
DAPI or Propidium Iodide (PI) was used for nuclear stain-
ing. The immunostained coverslips were examined under
a confocal laser scanning microscope LSM 510 (Carl Zeiss
GmbH, Jena, Germany). Images selected were representa-
tive of the majority of the cells present on each experiment
(n = 3 experiments performed).
Control experiments to test primary antibodies specificity
included incubation with pre-immune mouse and rabbit
sera. All confocal immunofluorescence microscopy
images presented correspond to single optical sections.
RTqPCR
Cells were harvested and total RNA were prepared and
checked for integrity as previously published [39]. cDNA
was generated from the RNA samples using SuperScript
(Invitrogen, Carlsbad, California). The primers used for
gene amplification by qPCR experiments were designed
using the Primer Express 3.0 Software (Applied Biosys-
tems, FosterCity, California) connected to the 7300 real
time PCR-system Thermocycler (Applied Biosystems, Fos-
ter City, CA). The following primers were used in this
study: hInsulin (F:5'TGCGGGGAACGAGGCTTCTTCTA3';
R:5'AGGGACCCCTCCAGGGCCAAG3'), hGlucagon
(F:5'ATAATCTT GCCGCCAGGGACTT3';R:5'ACGT-
GGCTAGCAGGTGA TGTTGT3'), hAmylase (F: 5'CTCG-
GCACAGTTATTCGCAAGT 3'; R:5'CGCTC TGTCAGATAC
GAAAC3'), hPro-hormone convertase 2 (F:5'CCAAC
TATAATGCCGAAGCAAGT3'; R: 5'CCGTGGCTGTTAAAC-
CAGT CA3'), hPro-hormone convertase 1 (F: 5'ATATTC-
CCGAAG AGGAGACCTTCA3'; R:5'GCCATTAGGAGAT
GTATCCCGTTCT3'), hChromogranin A (F:5'AAC
ACAGCGGTTTTGAAGATGA ACT3'; R: 5'CTCCATAA-
CATC CTTGGATGATGGCTCT3'), hPax6 (F:5'ACCAG
TGTCTACCAACCAATTCCA3'; R:5'TAGGTGTTTGTGAG-
GGCTGT GTCT3'), hSUR1 (F:5'CTGGTGATCCTCTAT
GGGATGCT3'; R: 5'CTTCACTCCCTCGGTGTCTTGA3'),
hMBs (F:5'TGGACCTG GTTGTTCACTCCTT; R: 5' CA
ACAGCATCATGAGGGTTTTC) and hHypoxanthine phos-
phoribosyl transferase (HPRT) (F:5'GAAGTC TTGC
TCGAGATGTGA3'; R:5'TCCAGCAGGTCAGCAAAGAAT
3'). To quantify the products formed during the RTqPCR
reaction, the SYBR® Green Dye reagent (Applied Biosys-
tems, Foster City, CA, EUA) was used [40]. Assessment of
data generated during amplification was performed using
the 7300 Real-time PCR System Sequence Detection Soft-
ware (Applied Biosystems, Foster City, CA). All reactions
were performed in triplicates (n = 4 independent experi-
ments). The relative expression of a target gene was deter-
mined in comparison to a reference gene [41].
Accumulated insulin, C-peptide, proinsulin release and 
insulin content determination
Cells were cultured in medium supplemented with 100
units/mL penicillin, 0.5% FCS (glucose final concentration:
5.6 mM) for 4 days. Accumulated insulin and C-peptide
release were quantified by the electrochemiluminescence
assay ELECSYS(Roche Diagnostics, Indianapolis, IN)[42].
Accumulted proinsulin release was quantified by radioim-
munoassay at the São Paulo Radioimmunoassay Centre
(CRIESP). Cells were then lysed to determine insulin and
DNA content as described elsewhere [28].
Glucose-induced insulin secretion
Cells were cultured in adherence, as previously described.
Cultures were washed with PBS and incubated for 2 h with
RPMI 1640 without glucose (Cultilab, Campinas, Brazil)
supplemented with 0.5% BSA and 2.8 or 20 mM glucose.BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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Secreted insulin was quantified in media collected from
each well by ELECSYS. The stimulation index for each
group of cultures was calculated by dividing the value of
insulin secretion at 20 mM glucose by that obtained upon
2.8 mM glucose incubation.
Cytogenetics
Semiconfluent cultures were treated with 0.1 μg/mL N-
deacetyl-N-Methylcolchicine (Life Technologies Inc.,
Carlsbald, CA) for 2 h at 37°C and detached with trypsin.
Hypotonic treatment was performed in 0.075 M potas-
sium chloride for 10 min at 37°C, and then cells were
fixed with 3:1 methanol: glacial acetic acid, dropped on
slides and air-dried. The slides were stained with 3%
Giemsa (Sigma Chemicals Co.). GTG and CBG banding
were performed according to routine techniques [43].
Doubling time
The doubling time of the in vitro cell cultures was deter-
mined by plating the 2 × 105 cells/well in six-well plates.
After 24, 48, 72, 120 and 168 h, triplicate cultures from
each time-point were fixed and counted. The population
doubling time was calculated from the log phase of the
growth curve.
Cell proliferation
4 × 104 viable cells/mL were seeded, in triplicate, in 24
multiwell plates in medium supplemented with 10% FCS.
After 24 h, the cells were serum starved in CMRL supple-
mented with 0.1% FCS for another 24 h and then sub-
jected to a 48 h treatment with different growth factors or
their corresponding vehicles, as negative controls (EGF or
IGF: 0.2 g/mL, 2 ng/mL, 20 ng/mL and 200 ng/mL; rhPRL:
20 μg/mL, 100 μg/mL and 300 μg/mL). Cells were then
harvested with trypsin-EDTA, fixed with 3.7% formalde-
hyde and counted in an electronic CC530 cell counter
(CELM, Sao Paulo, SP, Brasil).
Clonogenic assay
0.8 × 103 and 1.6 × 103 monodispersed cells were seeded
on 6-multiwell plates (Corning, NY) in medium contain-
ing 10% FCS. Medium was changed every 72 h. After 10
days of seeding, monolayers were washed, fixed with 5%
acetic acid in methanol and stained with crystal violet.
Plating efficiency was defined as the percentage of cells
which were able to grow as colonies of more than 10 cells.
Anchorage-independent growth
To evaluate cell-cell adhesion, 24-multiwell plates were
coated with a 1% agar (Invitrogene life technologies,
Carlsbad, CA) underlayer to prevent attachment. 3 × 104
VGA, CPR and APM cells, were seeded in suspension in
complete medium containing 10% FCS. At 4 days, the
spheroids formed were counted.
Serum depletion
The effect of serum withdrawal was assayed by seeding 1
× 104 cells in a 96-multiwell plate in medium containing
10% FCS and, after 24 h, washing with PBS and cultured
cells in serum-free medium for 96 h. Cell viability was
assessed by reduction of the tetrazolium salt (MTS) to the
formazan product in viable cells (Cell Titer 96 TM,
Promega Corp) as calculated by the 492/620 nm absorb-
ance ratio.
Doxorubicin treatment
1 × 104 VGA, CPR and APM cells were seeded in 96-multi-
well plates in medium containing 10% FCS. Subconfluent
monolayers were washed with PBS and cultured in the
presence of 0.75, 1.5, 3, 6 and 12 μM of Doxorubicin for
48 h. The susceptibility to this drug was evaluated by MTS
assay. The IC50, that represents the concentration of a
drug that is required for 50% reduction in cell viability,
was calculated for each cell line.
Adhesion to plastic, BSA, fibronectin (FN), laminin (LN) 
and Collagen type IV (Col IV)
Wells from 6 multiwell plates were coated with FN (2 μg/
cm2) (Sigma), LN (4 μg/cm2) (Sigma) and Collagen type
IV (Col IV, 2.5 μg/cm2) (Sigma) in PBS at room tempera-
ture for 60 min. Then, 3 × 104 cells per well were seeded
in serum free medium and incubated for 2 h at 37°C.
Adherent cells were washed with PBS, trypsinized and
counted in triplicates. The rate of cell adhesion was
expressed as the percentage of the total number of cells
seeded.
Analysis of cell adhesion molecules
Adhesion molecules expression was evaluated by IF and
Western blot (WB), as described by Peters et al. [44]. Con-
fluent monolayers were washed with PBS and then lysed
with Lysis Buffer (PBS-1% Triton X-100) containing pro-
tease-inhibitors (10 μg/mL PMSF, 10 μg/mL aprotinin, 10
μg/mL leupeptin, 1 μg/mL pepstatin). WB analyses were
carried out using PVDF membranes (BioRad, Hercules,
CA). Blocked membranes were then incubated with spe-
cific antibodies (anti-β1-Integrin, anti-E-Cadherin, anti-α-
Catenin and anti-Actin) and then incubated with peroxi-
dase-conjugated secondary antibody (Amersham-Phar-
macia-Biotech). Chemiluminescence was detected using
ECL reagent kit (Amersham-Pharmacia-Biotech). Espe-
cific bands were analyzed by densitometry (OD) (Molec-
ular AnalystTM GS-700, BioRad).
Cell spreading assay
About 5 × 104 cells from all cell lines were seeded onto
plastic Petri dishes (35 mm, Corning, NY) and allowed to
adhere for 60 min. Non-adherent cells were removed
through washing with PBS and the percentage of spread-BMC Cell Biology 2009, 10:49 http://www.biomedcentral.com/1471-2121/10/49
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ing cells was determined at 45 min by scoring 200–300
cells under a phase-contrast microscope (Nikon, Tokyo,
Japan). Data were collected by random observation at
least in triplicate. Rounded refringent cells were included
in the non-spreading group, and cells with a flattened
round base or with lamella or filopodia were included in
the spreading group. The rate of cell spreading was
expressed as the percentage of the total number of cells
seeded.
Migration assay
To determine the migratory capacity of the different cell
lines, a wound-healing assay was used [44]. Briefly, 5 ×
105  cells were seeded onto 60 mm plastic dishes in
medium supplemented with 10% FCS. When cells
reached confluence, parallel wounds of about 400 μm
width were made on the monolayers using a pipet tip. At
time 0 and after 18 h of incubation, photographs of the
same area were taken to determine the wound-healing
level. Images were evaluated by the image-Pro Plus 5.1
software (Media Cybernetics Inc., Bethesda, MD).
Cell invasion
The invasive capacity of each cell line was studied using
"Transwell" chambers (Corning), in 24 wells plates. Fil-
ters of 8 μm/pore, were covered in their basal face with
0.1% of gelatin, and on the top face with 250 μg/ml of
basal membrane reconstituted Matrigel (Becton Dickin-
son Labware). FN, (8 μg/ml, Sigma) was used as chemoat-
tractant. 5 × 105 cells were seeded onto the filter, in
medium containing 2% FCS. After 22 h at 37°C in a 5%
CO2 atmosphere, cells on the upper surface of the filters
were removed by wiping with cotton swabs and filters
were removed, fixed with formaldehyde and stained with
haematoxylin and eosin. We considered invasive, those
cells able to pass through the pores to the other face of the
filter.
Preparation of conditioned medium
To evaluate secreted proteases, conditioned medium was
prepared as previously described [44]. Semiconfluent
monolayers in 24 well plates, corresponding to the differ-
ent cell lines, were extensively washed with PBS to elimi-
nate serum traces. 200 μl of serum-free D-MEM was added
and the incubation was continued for 24 h. Conditioned
medium was individually harvested from each well and
the remaining monolayers were scraped and lysed. Cell
protein content was measured by Bradford method.
Quantification of uPA activity by radial caseinolysis
A radial caseinolytic method was employed, as previously
described [45]. Plasminogen-free casein-agarose gels were
used to test plasminogen-independent activity. Briefly,
mixtures of 1.25% agarose in deionised water, 20 mg
powdered fat-free milk as a casein source, 2 μg/mL plas-
minogen (Chromogenix) and 100 mM Tris-Cl (pH = 8)
were prepared and kept at 46°C. The diameters of the lytic
zones were referred to a purified urokinase (Serono)
standard curve ranging from 0.2 to 25 IU/mL, and nor-
malized to the original cell culture protein content.
Detection of MMP activity by quantitative zymography
Collagenolytic activity secreted by the different insuli-
noma cell lines was determined in 9% SDS-PAGE copoly-
merized with 0.1% heat-denatured type I collagen
(gelatin, Invitrogene life techonologies, Carlsbad, CA
BRL), as previously described [46,47]. After running, gels
were washed in 2% Triton X-100 and incubated for 72 h
at 37°C in 0.25 M Tris -HCl/1 M NaCl/25 mM CaCl2
buffer (pH 7.4) for specific activity detection, or in the
same solution containing 40 mM EDTA to detect non-spe-
cific activity. Gels were fixed and stained with Coomassie
Blue R-250 and distained in 30% methanol-10% acetic
acid in water. Gelatinolytic bands, visualized by negative
staining, were densitometered with an image analyzer
(Bio-Rad Densitometer, model GS-670). MMP activity is
expressed as arbitrary units (AU) per mg cell protein.
Statistical analysis
All experiments were performed at least in triplicate. The
significance of differences between groups was calculated
by applying ANOVA and Bonferroni's test, as indicated. A
value of p < 0.05 was considered to be significant.
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